Global Radiopharmaceuticals in Nuclear Medical Supply, Demand and Key Producers, 2023-2029

Description

The global Radiopharmaceuticals in Nuclear Medical market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these agents.

This report studies the global Radiopharmaceuticals in Nuclear Medical production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radiopharmaceuticals in Nuclear Medical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceuticals in Nuclear Medical that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Radiopharmaceuticals in Nuclear Medical total production and demand, 2018-2029, (K MT)
Global Radiopharmaceuticals in Nuclear Medical total production value, 2018-2029, (USD Million)
Global Radiopharmaceuticals in Nuclear Medical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Radiopharmaceuticals in Nuclear Medical consumption by region & country, CAGR, 2018-2029 & (K MT)
U.S. VS China: Radiopharmaceuticals in Nuclear Medical domestic production, consumption, key domestic manufacturers and share
Global Radiopharmaceuticals in Nuclear Medical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K MT)
Global Radiopharmaceuticals in Nuclear Medical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K MT)
Global Radiopharmaceuticals in Nuclear Medical production by Application production, value, CAGR, 2018-2029, (USD Million) & (K MT).

This reports profiles key players in the global Radiopharmaceuticals in Nuclear Medical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging, Cambridge Isotope Laboratories, Cardinal Health, Medtronic, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group and Lantheus Medical Imaging, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceuticals in Nuclear Medical market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Radiopharmaceuticals in Nuclear Medical Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Radiopharmaceuticals in Nuclear Medical Market, Segmentation by Type
    Diagnostic Radiopharmaceuticals
    Therapy Radiopharmaceuticals
    Enriched Stable Isotopes

Global Radiopharmaceuticals in Nuclear Medical Market, Segmentation by Application
    Diagnostic Application
    Therapeutic Application
    Research
    Pharmaceutical
    Industrial

Companies Profiled:
    Bracco Imaging
    Cambridge Isotope Laboratories
    Cardinal Health
    Medtronic
    Eczacibasi-Monrol
    Fujifilm Holdings Corporation
    GE Healthcare (Subsidiary Of General Electric Company)
    IBA Group
    Lantheus Medical Imaging
    Nordion
    Ntp Radioisotopes
    Siemens Healthcare
    Taiyo Nippon Sanso Corporation
    Urenco Limited
    Rotem Industries

Key Questions Answered
1. How big is the global Radiopharmaceuticals in Nuclear Medical market?
2. What is the demand of the global Radiopharmaceuticals in Nuclear Medical market?
3. What is the year over year growth of the global Radiopharmaceuticals in Nuclear Medical market?
4. What is the production and production value of the global Radiopharmaceuticals in Nuclear Medical market?
5. Who are the key producers in the global Radiopharmaceuticals in Nuclear Medical market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Radiopharmaceuticals in Nuclear Medical Introduction
    1.2 World Radiopharmaceuticals in Nuclear Medical Supply & Forecast
        1.2.1 World Radiopharmaceuticals in Nuclear Medical Production Value (2018 & 2022 & 2029)
        1.2.2 World Radiopharmaceuticals in Nuclear Medical Production (2018-2029)
        1.2.3 World Radiopharmaceuticals in Nuclear Medical Pricing Trends (2018-2029)
    1.3 World Radiopharmaceuticals in Nuclear Medical Production by Region (Based on Production Site)
        1.3.1 World Radiopharmaceuticals in Nuclear Medical Production Value by Region (2018-2029)
        1.3.2 World Radiopharmaceuticals in Nuclear Medical Production by Region (2018-2029)
        1.3.3 World Radiopharmaceuticals in Nuclear Medical Average Price by Region (2018-2029)
        1.3.4 North America Radiopharmaceuticals in Nuclear Medical Production (2018-2029)
        1.3.5 Europe Radiopharmaceuticals in Nuclear Medical Production (2018-2029)
        1.3.6 China Radiopharmaceuticals in Nuclear Medical Production (2018-2029)
        1.3.7 Japan Radiopharmaceuticals in Nuclear Medical Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Radiopharmaceuticals in Nuclear Medical Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Radiopharmaceuticals in Nuclear Medical Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Radiopharmaceuticals in Nuclear Medical Demand (2018-2029)
    2.2 World Radiopharmaceuticals in Nuclear Medical Consumption by Region
        2.2.1 World Radiopharmaceuticals in Nuclear Medical Consumption by Region (2018-2023)
        2.2.2 World Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2024-2029)
    2.3 United States Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029)
    2.4 China Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029)
    2.5 Europe Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029)
    2.6 Japan Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029)
    2.7 South Korea Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029)
    2.8 ASEAN Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029)
    2.9 India Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029)

3 World Radiopharmaceuticals in Nuclear Medical Manufacturers Competitive Analysis
    3.1 World Radiopharmaceuticals in Nuclear Medical Production Value by Manufacturer (2018-2023)
    3.2 World Radiopharmaceuticals in Nuclear Medical Production by Manufacturer (2018-2023)
    3.3 World Radiopharmaceuticals in Nuclear Medical Average Price by Manufacturer (2018-2023)
    3.4 Radiopharmaceuticals in Nuclear Medical Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Radiopharmaceuticals in Nuclear Medical Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Radiopharmaceuticals in Nuclear Medical in 2022
        3.5.3 Global Concentration Ratios (CR8) for Radiopharmaceuticals in Nuclear Medical in 2022
    3.6 Radiopharmaceuticals in Nuclear Medical Market: Overall Company Footprint Analysis
        3.6.1 Radiopharmaceuticals in Nuclear Medical Market: Region Footprint
        3.6.2 Radiopharmaceuticals in Nuclear Medical Market: Company Product Type Footprint
        3.6.3 Radiopharmaceuticals in Nuclear Medical Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Radiopharmaceuticals in Nuclear Medical Production Value Comparison
        4.1.1 United States VS China: Radiopharmaceuticals in Nuclear Medical Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Radiopharmaceuticals in Nuclear Medical Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Radiopharmaceuticals in Nuclear Medical Production Comparison
        4.2.1 United States VS China: Radiopharmaceuticals in Nuclear Medical Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Radiopharmaceuticals in Nuclear Medical Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Radiopharmaceuticals in Nuclear Medical Consumption Comparison
        4.3.1 United States VS China: Radiopharmaceuticals in Nuclear Medical Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Radiopharmaceuticals in Nuclear Medical Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Radiopharmaceuticals in Nuclear Medical Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Radiopharmaceuticals in Nuclear Medical Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production (2018-2023)
    4.5 China Based Radiopharmaceuticals in Nuclear Medical Manufacturers and Market Share
        4.5.1 China Based Radiopharmaceuticals in Nuclear Medical Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value (2018-2023)
        4.5.3 China Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production (2018-2023)
    4.6 Rest of World Based Radiopharmaceuticals in Nuclear Medical Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Radiopharmaceuticals in Nuclear Medical Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production (2018-2023)

5 Market Analysis by Type
    5.1 World Radiopharmaceuticals in Nuclear Medical Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Diagnostic Radiopharmaceuticals
        5.2.2 Therapy Radiopharmaceuticals
        5.2.3 Enriched Stable Isotopes
    5.3 Market Segment by Type
        5.3.1 World Radiopharmaceuticals in Nuclear Medical Production by Type (2018-2029)
        5.3.2 World Radiopharmaceuticals in Nuclear Medical Production Value by Type (2018-2029)
        5.3.3 World Radiopharmaceuticals in Nuclear Medical Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Radiopharmaceuticals in Nuclear Medical Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Diagnostic Application
        6.2.2 Therapeutic Application
        6.2.3 Research
        6.2.4 Pharmaceutical
        6.2.5 Industrial
    6.3 Market Segment by Application
        6.3.1 World Radiopharmaceuticals in Nuclear Medical Production by Application (2018-2029)
        6.3.2 World Radiopharmaceuticals in Nuclear Medical Production Value by Application (2018-2029)
        6.3.3 World Radiopharmaceuticals in Nuclear Medical Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Bracco Imaging
        7.1.1 Bracco Imaging Details
        7.1.2 Bracco Imaging Major Business
        7.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product and Services
        7.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Bracco Imaging Recent Developments/Updates
        7.1.6 Bracco Imaging Competitive Strengths & Weaknesses
    7.2 Cambridge Isotope Laboratories
        7.2.1 Cambridge Isotope Laboratories Details
        7.2.2 Cambridge Isotope Laboratories Major Business
        7.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product and Services
        7.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Cambridge Isotope Laboratories Recent Developments/Updates
        7.2.6 Cambridge Isotope Laboratories Competitive Strengths & Weaknesses
    7.3 Cardinal Health
        7.3.1 Cardinal Health Details
        7.3.2 Cardinal Health Major Business
        7.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Product and Services
        7.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Cardinal Health Recent Developments/Updates
        7.3.6 Cardinal Health Competitive Strengths & Weaknesses
    7.4 Medtronic
        7.4.1 Medtronic Details
        7.4.2 Medtronic Major Business
        7.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Product and Services
        7.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Medtronic Recent Developments/Updates
        7.4.6 Medtronic Competitive Strengths & Weaknesses
    7.5 Eczacibasi-Monrol
        7.5.1 Eczacibasi-Monrol Details
        7.5.2 Eczacibasi-Monrol Major Business
        7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product and Services
        7.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Eczacibasi-Monrol Recent Developments/Updates
        7.5.6 Eczacibasi-Monrol Competitive Strengths & Weaknesses
    7.6 Fujifilm Holdings Corporation
        7.6.1 Fujifilm Holdings Corporation Details
        7.6.2 Fujifilm Holdings Corporation Major Business
        7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product and Services
        7.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Fujifilm Holdings Corporation Recent Developments/Updates
        7.6.6 Fujifilm Holdings Corporation Competitive Strengths & Weaknesses
    7.7 GE Healthcare (Subsidiary Of General Electric Company)
        7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Details
        7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Major Business
        7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product and Services
        7.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Developments/Updates
        7.7.6 GE Healthcare (Subsidiary Of General Electric Company) Competitive Strengths & Weaknesses
    7.8 IBA Group
        7.8.1 IBA Group Details
        7.8.2 IBA Group Major Business
        7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Product and Services
        7.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 IBA Group Recent Developments/Updates
        7.8.6 IBA Group Competitive Strengths & Weaknesses
    7.9 Lantheus Medical Imaging
        7.9.1 Lantheus Medical Imaging Details
        7.9.2 Lantheus Medical Imaging Major Business
        7.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product and Services
        7.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Lantheus Medical Imaging Recent Developments/Updates
        7.9.6 Lantheus Medical Imaging Competitive Strengths & Weaknesses
    7.10 Nordion
        7.10.1 Nordion Details
        7.10.2 Nordion Major Business
        7.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Product and Services
        7.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Nordion Recent Developments/Updates
        7.10.6 Nordion Competitive Strengths & Weaknesses
    7.11 Ntp Radioisotopes
        7.11.1 Ntp Radioisotopes Details
        7.11.2 Ntp Radioisotopes Major Business
        7.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product and Services
        7.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Ntp Radioisotopes Recent Developments/Updates
        7.11.6 Ntp Radioisotopes Competitive Strengths & Weaknesses
    7.12 Siemens Healthcare
        7.12.1 Siemens Healthcare Details
        7.12.2 Siemens Healthcare Major Business
        7.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product and Services
        7.12.4 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Siemens Healthcare Recent Developments/Updates
        7.12.6 Siemens Healthcare Competitive Strengths & Weaknesses
    7.13 Taiyo Nippon Sanso Corporation
        7.13.1 Taiyo Nippon Sanso Corporation Details
        7.13.2 Taiyo Nippon Sanso Corporation Major Business
        7.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product and Services
        7.13.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Taiyo Nippon Sanso Corporation Recent Developments/Updates
        7.13.6 Taiyo Nippon Sanso Corporation Competitive Strengths & Weaknesses
    7.14 Urenco Limited
        7.14.1 Urenco Limited Details
        7.14.2 Urenco Limited Major Business
        7.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Product and Services
        7.14.4 Urenco Limited Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Urenco Limited Recent Developments/Updates
        7.14.6 Urenco Limited Competitive Strengths & Weaknesses
    7.15 Rotem Industries
        7.15.1 Rotem Industries Details
        7.15.2 Rotem Industries Major Business
        7.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Product and Services
        7.15.4 Rotem Industries Radiopharmaceuticals in Nuclear Medical Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Rotem Industries Recent Developments/Updates
        7.15.6 Rotem Industries Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Radiopharmaceuticals in Nuclear Medical Industry Chain
    8.2 Radiopharmaceuticals in Nuclear Medical Upstream Analysis
        8.2.1 Radiopharmaceuticals in Nuclear Medical Core Raw Materials
        8.2.2 Main Manufacturers of Radiopharmaceuticals in Nuclear Medical Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Radiopharmaceuticals in Nuclear Medical Production Mode
    8.6 Radiopharmaceuticals in Nuclear Medical Procurement Model
    8.7 Radiopharmaceuticals in Nuclear Medical Industry Sales Model and Sales Channels
        8.7.1 Radiopharmaceuticals in Nuclear Medical Sales Model
        8.7.2 Radiopharmaceuticals in Nuclear Medical Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Radiopharmaceuticals in Nuclear Medical Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Radiopharmaceuticals in Nuclear Medical Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Radiopharmaceuticals in Nuclear Medical Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Radiopharmaceuticals in Nuclear Medical Production Value Market Share by Region (2018-2023)
    Table 5. World Radiopharmaceuticals in Nuclear Medical Production Value Market Share by Region (2024-2029)
    Table 6. World Radiopharmaceuticals in Nuclear Medical Production by Region (2018-2023) & (K MT)
    Table 7. World Radiopharmaceuticals in Nuclear Medical Production by Region (2024-2029) & (K MT)
    Table 8. World Radiopharmaceuticals in Nuclear Medical Production Market Share by Region (2018-2023)
    Table 9. World Radiopharmaceuticals in Nuclear Medical Production Market Share by Region (2024-2029)
    Table 10. World Radiopharmaceuticals in Nuclear Medical Average Price by Region (2018-2023) & (USD/MT)
    Table 11. World Radiopharmaceuticals in Nuclear Medical Average Price by Region (2024-2029) & (USD/MT)
    Table 12. Radiopharmaceuticals in Nuclear Medical Major Market Trends
    Table 13. World Radiopharmaceuticals in Nuclear Medical Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K MT)
    Table 14. World Radiopharmaceuticals in Nuclear Medical Consumption by Region (2018-2023) & (K MT)
    Table 15. World Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2024-2029) & (K MT)
    Table 16. World Radiopharmaceuticals in Nuclear Medical Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Radiopharmaceuticals in Nuclear Medical Producers in 2022
    Table 18. World Radiopharmaceuticals in Nuclear Medical Production by Manufacturer (2018-2023) & (K MT)
    Table 19. Production Market Share of Key Radiopharmaceuticals in Nuclear Medical Producers in 2022
    Table 20. World Radiopharmaceuticals in Nuclear Medical Average Price by Manufacturer (2018-2023) & (USD/MT)
    Table 21. Global Radiopharmaceuticals in Nuclear Medical Company Evaluation Quadrant
    Table 22. World Radiopharmaceuticals in Nuclear Medical Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Radiopharmaceuticals in Nuclear Medical Production Site of Key Manufacturer
    Table 24. Radiopharmaceuticals in Nuclear Medical Market: Company Product Type Footprint
    Table 25. Radiopharmaceuticals in Nuclear Medical Market: Company Product Application Footprint
    Table 26. Radiopharmaceuticals in Nuclear Medical Competitive Factors
    Table 27. Radiopharmaceuticals in Nuclear Medical New Entrant and Capacity Expansion Plans
    Table 28. Radiopharmaceuticals in Nuclear Medical Mergers & Acquisitions Activity
    Table 29. United States VS China Radiopharmaceuticals in Nuclear Medical Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Radiopharmaceuticals in Nuclear Medical Production Comparison, (2018 & 2022 & 2029) & (K MT)
    Table 31. United States VS China Radiopharmaceuticals in Nuclear Medical Consumption Comparison, (2018 & 2022 & 2029) & (K MT)
    Table 32. United States Based Radiopharmaceuticals in Nuclear Medical Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production (2018-2023) & (K MT)
    Table 36. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Market Share (2018-2023)
    Table 37. China Based Radiopharmaceuticals in Nuclear Medical Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production (2018-2023) & (K MT)
    Table 41. China Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Market Share (2018-2023)
    Table 42. Rest of World Based Radiopharmaceuticals in Nuclear Medical Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production (2018-2023) & (K MT)
    Table 46. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Market Share (2018-2023)
    Table 47. World Radiopharmaceuticals in Nuclear Medical Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Radiopharmaceuticals in Nuclear Medical Production by Type (2018-2023) & (K MT)
    Table 49. World Radiopharmaceuticals in Nuclear Medical Production by Type (2024-2029) & (K MT)
    Table 50. World Radiopharmaceuticals in Nuclear Medical Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Radiopharmaceuticals in Nuclear Medical Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Radiopharmaceuticals in Nuclear Medical Average Price by Type (2018-2023) & (USD/MT)
    Table 53. World Radiopharmaceuticals in Nuclear Medical Average Price by Type (2024-2029) & (USD/MT)
    Table 54. World Radiopharmaceuticals in Nuclear Medical Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Radiopharmaceuticals in Nuclear Medical Production by Application (2018-2023) & (K MT)
    Table 56. World Radiopharmaceuticals in Nuclear Medical Production by Application (2024-2029) & (K MT)
    Table 57. World Radiopharmaceuticals in Nuclear Medical Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Radiopharmaceuticals in Nuclear Medical Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Radiopharmaceuticals in Nuclear Medical Average Price by Application (2018-2023) & (USD/MT)
    Table 60. World Radiopharmaceuticals in Nuclear Medical Average Price by Application (2024-2029) & (USD/MT)
    Table 61. Bracco Imaging Basic Information, Manufacturing Base and Competitors
    Table 62. Bracco Imaging Major Business
    Table 63. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 64. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Bracco Imaging Recent Developments/Updates
    Table 66. Bracco Imaging Competitive Strengths & Weaknesses
    Table 67. Cambridge Isotope Laboratories Basic Information, Manufacturing Base and Competitors
    Table 68. Cambridge Isotope Laboratories Major Business
    Table 69. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 70. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Cambridge Isotope Laboratories Recent Developments/Updates
    Table 72. Cambridge Isotope Laboratories Competitive Strengths & Weaknesses
    Table 73. Cardinal Health Basic Information, Manufacturing Base and Competitors
    Table 74. Cardinal Health Major Business
    Table 75. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 76. Cardinal Health Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Cardinal Health Recent Developments/Updates
    Table 78. Cardinal Health Competitive Strengths & Weaknesses
    Table 79. Medtronic Basic Information, Manufacturing Base and Competitors
    Table 80. Medtronic Major Business
    Table 81. Medtronic Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 82. Medtronic Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Medtronic Recent Developments/Updates
    Table 84. Medtronic Competitive Strengths & Weaknesses
    Table 85. Eczacibasi-Monrol Basic Information, Manufacturing Base and Competitors
    Table 86. Eczacibasi-Monrol Major Business
    Table 87. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 88. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Eczacibasi-Monrol Recent Developments/Updates
    Table 90. Eczacibasi-Monrol Competitive Strengths & Weaknesses
    Table 91. Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
    Table 92. Fujifilm Holdings Corporation Major Business
    Table 93. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 94. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Fujifilm Holdings Corporation Recent Developments/Updates
    Table 96. Fujifilm Holdings Corporation Competitive Strengths & Weaknesses
    Table 97. GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Manufacturing Base and Competitors
    Table 98. GE Healthcare (Subsidiary Of General Electric Company) Major Business
    Table 99. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 100. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. GE Healthcare (Subsidiary Of General Electric Company) Recent Developments/Updates
    Table 102. GE Healthcare (Subsidiary Of General Electric Company) Competitive Strengths & Weaknesses
    Table 103. IBA Group Basic Information, Manufacturing Base and Competitors
    Table 104. IBA Group Major Business
    Table 105. IBA Group Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 106. IBA Group Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. IBA Group Recent Developments/Updates
    Table 108. IBA Group Competitive Strengths & Weaknesses
    Table 109. Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors
    Table 110. Lantheus Medical Imaging Major Business
    Table 111. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 112. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Lantheus Medical Imaging Recent Developments/Updates
    Table 114. Lantheus Medical Imaging Competitive Strengths & Weaknesses
    Table 115. Nordion Basic Information, Manufacturing Base and Competitors
    Table 116. Nordion Major Business
    Table 117. Nordion Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 118. Nordion Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Nordion Recent Developments/Updates
    Table 120. Nordion Competitive Strengths & Weaknesses
    Table 121. Ntp Radioisotopes Basic Information, Manufacturing Base and Competitors
    Table 122. Ntp Radioisotopes Major Business
    Table 123. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 124. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Ntp Radioisotopes Recent Developments/Updates
    Table 126. Ntp Radioisotopes Competitive Strengths & Weaknesses
    Table 127. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
    Table 128. Siemens Healthcare Major Business
    Table 129. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 130. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Siemens Healthcare Recent Developments/Updates
    Table 132. Siemens Healthcare Competitive Strengths & Weaknesses
    Table 133. Taiyo Nippon Sanso Corporation Basic Information, Manufacturing Base and Competitors
    Table 134. Taiyo Nippon Sanso Corporation Major Business
    Table 135. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 136. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Taiyo Nippon Sanso Corporation Recent Developments/Updates
    Table 138. Taiyo Nippon Sanso Corporation Competitive Strengths & Weaknesses
    Table 139. Urenco Limited Basic Information, Manufacturing Base and Competitors
    Table 140. Urenco Limited Major Business
    Table 141. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 142. Urenco Limited Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Urenco Limited Recent Developments/Updates
    Table 144. Rotem Industries Basic Information, Manufacturing Base and Competitors
    Table 145. Rotem Industries Major Business
    Table 146. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product and Services
    Table 147. Rotem Industries Radiopharmaceuticals in Nuclear Medical Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 148. Global Key Players of Radiopharmaceuticals in Nuclear Medical Upstream (Raw Materials)
    Table 149. Radiopharmaceuticals in Nuclear Medical Typical Customers
    Table 150. Radiopharmaceuticals in Nuclear Medical Typical Distributors
List of Figure
    Figure 1. Radiopharmaceuticals in Nuclear Medical Picture
    Figure 2. World Radiopharmaceuticals in Nuclear Medical Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Radiopharmaceuticals in Nuclear Medical Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Radiopharmaceuticals in Nuclear Medical Production (2018-2029) & (K MT)
    Figure 5. World Radiopharmaceuticals in Nuclear Medical Average Price (2018-2029) & (USD/MT)
    Figure 6. World Radiopharmaceuticals in Nuclear Medical Production Value Market Share by Region (2018-2029)
    Figure 7. World Radiopharmaceuticals in Nuclear Medical Production Market Share by Region (2018-2029)
    Figure 8. North America Radiopharmaceuticals in Nuclear Medical Production (2018-2029) & (K MT)
    Figure 9. Europe Radiopharmaceuticals in Nuclear Medical Production (2018-2029) & (K MT)
    Figure 10. China Radiopharmaceuticals in Nuclear Medical Production (2018-2029) & (K MT)
    Figure 11. Japan Radiopharmaceuticals in Nuclear Medical Production (2018-2029) & (K MT)
    Figure 12. Radiopharmaceuticals in Nuclear Medical Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029) & (K MT)
    Figure 15. World Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Region (2018-2029)
    Figure 16. United States Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029) & (K MT)
    Figure 17. China Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029) & (K MT)
    Figure 18. Europe Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029) & (K MT)
    Figure 19. Japan Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029) & (K MT)
    Figure 20. South Korea Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029) & (K MT)
    Figure 21. ASEAN Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029) & (K MT)
    Figure 22. India Radiopharmaceuticals in Nuclear Medical Consumption (2018-2029) & (K MT)
    Figure 23. Producer Shipments of Radiopharmaceuticals in Nuclear Medical by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceuticals in Nuclear Medical Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceuticals in Nuclear Medical Markets in 2022
    Figure 26. United States VS China: Radiopharmaceuticals in Nuclear Medical Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Radiopharmaceuticals in Nuclear Medical Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Radiopharmaceuticals in Nuclear Medical Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Market Share 2022
    Figure 30. China Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Radiopharmaceuticals in Nuclear Medical Production Market Share 2022
    Figure 32. World Radiopharmaceuticals in Nuclear Medical Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Radiopharmaceuticals in Nuclear Medical Production Value Market Share by Type in 2022
    Figure 34. Diagnostic Radiopharmaceuticals
    Figure 35. Therapy Radiopharmaceuticals
    Figure 36. Enriched Stable Isotopes
    Figure 37. World Radiopharmaceuticals in Nuclear Medical Production Market Share by Type (2018-2029)
    Figure 38. World Radiopharmaceuticals in Nuclear Medical Production Value Market Share by Type (2018-2029)
    Figure 39. World Radiopharmaceuticals in Nuclear Medical Average Price by Type (2018-2029) & (USD/MT)
    Figure 40. World Radiopharmaceuticals in Nuclear Medical Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Radiopharmaceuticals in Nuclear Medical Production Value Market Share by Application in 2022
    Figure 42. Diagnostic Application
    Figure 43. Therapeutic Application
    Figure 44. Research
    Figure 45. Pharmaceutical
    Figure 46. Industrial
    Figure 47. World Radiopharmaceuticals in Nuclear Medical Production Market Share by Application (2018-2029)
    Figure 48. World Radiopharmaceuticals in Nuclear Medical Production Value Market Share by Application (2018-2029)
    Figure 49. World Radiopharmaceuticals in Nuclear Medical Average Price by Application (2018-2029) & (USD/MT)
    Figure 50. Radiopharmaceuticals in Nuclear Medical Industry Chain
    Figure 51. Radiopharmaceuticals in Nuclear Medical Procurement Model
    Figure 52. Radiopharmaceuticals in Nuclear Medical Sales Model
    Figure 53. Radiopharmaceuticals in Nuclear Medical Sales Channels, Direct Sales, and Distribution
    Figure 54. Methodology
    Figure 55. Research Process and Data Source

Companies Mentioned

Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Medtronic
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries